drugset / Trial / NCT03921268
Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402
RandomizedCrossoverOpen-labelTreatment
Summary
To evaluate and compare the pharmacokinetics profiles of AZD1402 after oral inhalation as an inhalation powder and a nebuliser solution. To further assess the safety and tolerability of single doses of AZD1402 in healthy volunteers. To evaluate the taste characteristics of the test formulations.
Timeline
- Start
- 2019-03-25
- Primary completion
- 2019-06-13
- Completion
- 2019-06-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elarekibep | Protein / enzyme biologic | — | Inhaled |